{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/AEON/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-17T01:27:41.756Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11930,"canonical_name":"AEON Biopharma, Inc.","cik":"0001837607","uei":null,"lei":null,"duns":null,"ticker":"AEON"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":24},"count":24,"timeline":[{"ts":"2026-10-13","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — AEON Biopharma, Inc. — 2026-10-13","url_slug":"/sec/cik-0001837607/pre-14a/0001837607-26-000068","accession_number":"0001837607-26-000068","importance":30},{"ts":"2026-09-30","kind":"sec.filing","form_type":"8-K","title":"8-K — AEON Biopharma, Inc. — 2026-09-30","url_slug":"/sec/cik-0001837607/8-k/0001837607-26-000064","accession_number":"0001837607-26-000064","importance":35},{"ts":"2026-08-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — AEON Biopharma, Inc. — 2026-08-12","url_slug":"/sec/cik-0001837607/10-q/0001837607-26-000062","accession_number":"0001837607-26-000062","importance":45},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — AEON Biopharma, Inc. — 2026-08-12","url_slug":"/sec/cik-0001837607/8-k/0001837607-26-000061","accession_number":"0001837607-26-000061","importance":35},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K","title":"8-K — AEON Biopharma, Inc. — 2026-08-03","url_slug":"/sec/cik-0001837607/8-k/0001837607-26-000057","accession_number":"0001837607-26-000057","importance":35},{"ts":"2026-07-23","kind":"sec.filing","form_type":"8-K","title":"8-K — AEON Biopharma, Inc. — 2026-07-23","url_slug":"/sec/cik-0001837607/8-k/0001837607-26-000055","accession_number":"0001837607-26-000055","importance":35},{"ts":"2026-07-21","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Stonepine Capital Management, LLC — 2026-07-21","url_slug":"/sec/cik-0001440771/schedule-13g/0001440771-26-000012","accession_number":"0001440771-26-000012","importance":55},{"ts":"2026-07-15","kind":"sec.filing","form_type":"424B4","title":"424B4 — AEON Biopharma, Inc. — 2026-07-15","url_slug":"/sec/cik-0001837607/424b4/0001104659-26-083680","accession_number":"0001104659-26-083680","importance":55},{"ts":"2026-07-15","kind":"sec.filing","form_type":"8-K","title":"8-K — AEON Biopharma, Inc. — 2026-07-15","url_slug":"/sec/cik-0001837607/8-k/0001837607-26-000052","accession_number":"0001837607-26-000052","importance":35},{"ts":"2026-07-13","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — AEON Biopharma, Inc. — 2026-07-13","url_slug":"/sec/cik-0001837607/effect/9999999995-26-002285","accession_number":"9999999995-26-002285","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-1MEF","title":"S-1MEF — AEON Biopharma, Inc. — 2026-07-13","url_slug":"/sec/cik-0001837607/s-1mef/0001104659-26-083252","accession_number":"0001104659-26-083252","importance":30},{"ts":"2026-07-09","kind":"sec.filing","form_type":"S-1/A","title":"S-1/A — AEON Biopharma, Inc. — 2026-07-09","url_slug":"/sec/cik-0001837607/s-1-a/0001104659-26-082167","accession_number":"0001104659-26-082167","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"S-1","title":"S-1 — AEON Biopharma, Inc. — 2026-07-08","url_slug":"/sec/cik-0001837607/s-1/0001104659-26-081860","accession_number":"0001104659-26-081860","importance":65},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — PALMISANO ROBERT J — 2026-06-22","url_slug":"/sec/cik-0001138646/4/0001104659-26-076513","accession_number":"0001104659-26-076513","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"8-K","title":"8-K — AEON Biopharma, Inc. — 2026-06-17","url_slug":"/sec/cik-0001837607/8-k/0001837607-26-000046","accession_number":"0001837607-26-000046","importance":35},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"PALMISANO ROBERT J","title":"","shares":222684,"price_per_share":0,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"Thunen Shelley B","title":"","shares":222684,"price_per_share":0,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"FISCHER JOST","title":"","shares":222684,"price_per_share":0,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"Carter Eric G","title":"","shares":222684,"price_per_share":0,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.insider.a","reporter":"Forth Marc","title":"","shares":222684,"price_per_share":0,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.filing","form_type":"DRS","title":"DRS — AEON Biopharma, Inc. — 2026-05-29","url_slug":"/sec/cik-0001837607/drs/0001104659-26-068203","accession_number":"0001104659-26-068203","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — AEON Biopharma, Inc. — 2026-05-14","url_slug":"/sec/cik-0001837607/10-q/0001837607-26-000042","accession_number":"0001837607-26-000042","importance":45},{"ts":"2026-05-14","kind":"sec.filing","form_type":"8-K","title":"8-K — AEON Biopharma, Inc. — 2026-05-14","url_slug":"/sec/cik-0001837607/8-k/0001837607-26-000043","accession_number":"0001837607-26-000043","importance":35},{"ts":"2026-05-14","kind":"sec.filing","form_type":"8-K","title":"8-K — AEON Biopharma, Inc. — 2026-05-14","url_slug":"/sec/cik-0001837607/8-k/0001837607-26-000041","accession_number":"0001837607-26-000041","importance":35}]}